Nonarteritic anterior ischemic optic neuropathy (NAION) is the most common form of
ischemic optic neuropathy and the second most common optic neuropathy. Patients are …

Background: Nonarteritic Anterior Ischemic Optic Neuropathy (NAION) is the second most
common cause of optic nerve-related permanent visual loss in adults. Aim: We aimed to …

Purpose To determine whether transcorneal electrical stimulation (TES) can improve the
visual function of patients with nonarteritic ischemic optic neuropathy (NAION) or traumatic …

Ischaemic optic neuropathy is of two types: anterior (AION) and posterior (PION), the first
involving the optic nerve head (ONH) and the second, the rest of the optic nerve …

OBJECTIVE: To study the effect of levodopa in improving visual function in patients treated
within 45 days of onset of nonarteritic anterior ischemic optic neuropathy (NAION). DESIGN …

Placebos have been traditionally regarded as deceptive therapies and have not been
understood in the broader context of social symbols and of interpersonal factors that …

Intense investigations in humans and animals are under way. Hopefully these studies will
enhance our understanding of the risk factors and pathophysiology of nonarteritic anterior …

Objective To describe visual acuity outcomes of patients in the Ischemic Optic Neuropathy
Decompression Trial (IONDT) after 24 months of follow-up. Design The IONDT is a single …

Background and purpose: Our work evaluates visual function before and after treatment with
cytidine‐5‐diphosphocholine (Citicoline) in patients with non‐arteritic ischaemic optic …

Although uncommon, alterations in vision and blindness after anesthesia for major surgical
procedures, particularly cardiopulmonary bypass or spine surgery, are well documented …